Literature DB >> 3010179

Electrophysiologic features of abetalipoproteinemia: functional consequences of vitamin E deficiency.

M F Brin, T A Pedley, R E Lovelace, R G Emerson, P Gouras, C MacKay, H J Kayden, J Levy, H Baker.   

Abstract

We performed electrophysiologic testing in 10 patients with abetalipoproteinemia (ABL). Peripheral nerve studies implied an axonal disorder. Visual evoked potentials demonstrated prolonged P100 latency in three patients and abnormal electroretinograms in six. Somatosensory evoked potentials indicated dorsal column dysfunction in eight patients. Brainstem auditory evoked potentials were normal. Findings were consistent with the known neuropathology of ABL and of experimental vitamin E deficiency. Stabilization or improvement in electrophysiologic findings occurred with vitamin E supplementation. Neurophysiologic tests document retinal, central somatosensory and peripheral nerve lesions in vitamin E deficiency and provide an objective indication of response to treatment.

Entities:  

Mesh:

Year:  1986        PMID: 3010179     DOI: 10.1212/wnl.36.5.669

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Vitamin e use in neurology.

Authors:  J Eaton
Journal:  West J Med       Date:  1989-05

2.  Lumbar and cortical somatosensory evoked potentials in rats with vitamin E deficiency.

Authors:  M A Goss-Sampson; A Kriss; J R Muddle; P K Thomas; D P Muller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-03       Impact factor: 10.154

3.  A case of abetalipoproteinaemia in a Polish family.

Authors:  M Kaciński; F Kaczmarski; W Miezyński; Z Grzenda-Adamek; B Miszczuk-Jamska; J Stopyrowa; J Sznajd
Journal:  Eur J Pediatr       Date:  1991-04       Impact factor: 3.183

4.  Alpha-tocopherol concentrations of the nervous system and selected tissues of adult dogs fed three levels of vitamin E.

Authors:  S R Pillai; M G Traber; J E Steiss; H J Kayden; N R Cox
Journal:  Lipids       Date:  1993-12       Impact factor: 1.880

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.